- Home
- GSK vs RCL Comparison
GSK vs RCL Comparison
Compare GSK & RCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSK
- RCL
- Stock Information
- Founded
- GSK 1715
- RCL 1968
- Country
- GSK United Kingdom
- RCL United States
- Employees
- GSK N/A
- RCL N/A
- Industry
- GSK Biotechnology: Pharmaceutical Preparations
- RCL Marine Transportation
- Sector
- GSK Health Care
- RCL Consumer Discretionary
- Exchange
- GSK Nasdaq
- RCL Nasdaq
- Market Cap
- GSK 77.1B
- RCL 63.0B
- IPO Year
- GSK N/A
- RCL N/A
- Fundamental
- Price
- GSK $39.32
- RCL $313.94
- Analyst Decision
- GSK Hold
- RCL Strong Buy
- Analyst Count
- GSK 2
- RCL 19
- Target Price
- GSK N/A
- RCL $329.95
- AVG Volume (30 Days)
- GSK 4.6M
- RCL 2.1M
- Earning Date
- GSK 07-30-2025
- RCL 07-29-2025
- Dividend Yield
- GSK 4.11%
- RCL 0.96%
- EPS Growth
- GSK N/A
- RCL 51.03
- EPS
- GSK 1.13
- RCL 13.47
- Revenue
- GSK $43,336,073,439.00
- RCL $17,184,000,000.00
- Revenue This Year
- GSK $5.56
- RCL $10.62
- Revenue Next Year
- GSK $5.08
- RCL $9.82
- P/E Ratio
- GSK $16.52
- RCL $23.31
- Revenue Growth
- GSK 0.59
- RCL 12.09
- 52 Week Low
- GSK $31.72
- RCL $154.08
- 52 Week High
- GSK $44.67
- RCL $355.91
- Technical
- Relative Strength Index (RSI)
- GSK 59.10
- RCL 46.58
- Support Level
- GSK $36.75
- RCL $297.84
- Resistance Level
- GSK $39.33
- RCL $318.23
- Average True Range (ATR)
- GSK 0.66
- RCL 9.84
- MACD
- GSK 0.26
- RCL -2.79
- Stochastic Oscillator
- GSK 99.61
- RCL 36.33
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.
About RCL Royal Caribbean Cruises Ltd.
Royal Caribbean is the world's second-largest cruise company, operating 66 ships across five global and partner brands in the cruise vacation industry. Brands the company operates include Royal Caribbean International, Celebrity Cruises, and Silversea. The company also has a 50% investment in a joint venture that operates TUI Cruises and Hapag-Lloyd Cruises. The selection of brands in the portfolio allows Royal to compete on the basis of innovation, quality of ships and service, variety of itineraries, choice of destinations, and price. The company completed the divestiture of its Azamara brand in 2021 and plans to launch its new Celebrity River Cruise brand in 2027.